生物素A通过NFκB通路抑制了通过IL-6刺激的内皮微粒诱导的内皮功能障碍,在珀斯病中通过NFκB通路抑制

Jianhong Liu1, Chengsen Lin1, Boxiang Li2

  • 1Department of Orthopedic Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

概括

生物素A (BCA) 可能通过减少IL-6诱导的内皮功能障碍来治疗珀斯病. BCA抑制NFκB通路,减少炎症标志物并改善细胞完整性.